| Jul 23 |
Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.
|
| Jul 18 |
Scilex Holding files to sell up to 3.5M shares by holders
|
| Jul 17 |
Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets i...
|
| Jul 2 |
Semnur Pharmaceuticals and Denali Capital Acquisition enter into a letter of intent for proposed business combination
|
| Jul 2 |
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination
|
| Jul 2 |
Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York
|
| Jul 1 |
Scilex says total product net sales for June grew in the range of 77% to 116%
|
| Jul 1 |
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024
|
| Jun 20 |
Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.
|
| Jun 14 |
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
|
